XBiotech Inc.
XBIT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626878
No open-market purchases or sales by XBiotech Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $4.56M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding XBiotech Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 61 | 64 | +3 |
| Shares | 4.21M | 4.03M | −172.1K (−4.1%) |
| Value | $46.8M | $34.9M | −$12.0M (−25.6%) |
New holders (10)
Institutions that held XBiotech Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 41,269 | $356.0K | 0.00% |
| State of Wisconsin Investment Board | 26,800 | $232.0K | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 23,603 | $204.0K | 0.00% |
| FMR LLC | 20,525 | $177.0K | 0.00% |
| Price T Rowe Associates Inc | 14,454 | $125.0K | 0.00% |
| PDT Partners, LLC | 13,064 | $113.0K | 0.01% |
| Two Sigma Investments, LP | 11,592 | $100.0K | 0.00% |
| Amalgamated Bank | 1,842 | $16.0K | 0.00% |
| Amalgamated Financial Corp. | 1,842 | $16.0K | 0.00% |
| Group One Trading, L.P. | 500 | $4.00K | 0.00% |
Sold out (7)
Institutions that held XBiotech Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Alps Advisors Inc | 35,176 | $392.0K |
| Invesco Ltd. | 24,831 | $277.0K |
| Marshall Wace, LLP | 24,176 | $269.0K |
| Ergoteles LLC | 14,200 | $158.0K |
| Susquehanna International Group, LLP | 13,007 | $145.0K |
| D. E. Shaw & Co., Inc. | 11,042 | $123.0K |
| Nisa Investment Advisors, LLC | 3,000 | $32.0K |